Clinical Trials at Memorial Sloan Kettering Westchester (All Protocol Activities)
As of July 2026, 54 paid clinical trials are recruiting at Memorial Sloan Kettering Westchester (All Protocol Activities) in Harrison, New York. Active studies at this site cover conditions such as Breast Cancer, Multiple Myeloma and Non-Small Cell Lung Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Harrison
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of CRD3874-SI in People With Leukemia
A Study of a Side Effects and Resource Navigation Program for People With Cancer
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
58 clinical trials at Memorial Sloan Kettering Westchester (All Protocol Activities)
·Clear filters·↓ Download CSVA Study of Ivonescimab in People With Non-Small Cell Lung Cancer
A Dietary Study for People With Clonal Hematopoiesis
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Registry for Bone Metastases
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
A Study of Isoquercetin in People With Ovarian Cancer
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
A Study of Herbal Supplements in Cancer Survivors With Constipation
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
A Registry for People With T-cell Lymphoma
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
A Study of Enasidenib in People With T-Cell Lymphoma
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
About research studies in Harrison
Harrison has approximately 307 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Common conditions studied in Harrison
- Breast Cancer (27 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (13 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-Small Cell Lung Cancer (10 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Prostate Cancer (10 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Acute Myeloid Leukemia (9 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Metastatic Breast Cancer (9 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Harrison
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Pfizer
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Harrison. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Harrison
Hipa.ai aggregates every recruiting study in Harrison from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Harrison?
There are approximately 307 recruiting clinical trials in Harrison, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Harrison pay participants?
Most recruiting trials in Harrison compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Harrison?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Harrison?
The most common conditions under active study in Harrison include Breast Cancer (27), Multiple Myeloma (13), Non-Small Cell Lung Cancer (10), Prostate Cancer (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Harrison?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Harrison on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Harrison?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Harrison?
Recruiting research sites in Harrison include Memorial Sloan Kettering Westchester (Limited Protocol Activities), Memorial Sloan Kettering Westchester, Memorial Sloan Kettering Westchester (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Harrison right now?
The largest active categories in Harrison are Cancer & tumors (250), Neurology & pain (3), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.